| Product Code: ETC7544308 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India generic oncology drug market import shipments exhibited steady growth with a CAGR of 3.0 from 2020 to 2024. Notably, there was a significant uptick in growth between 2023 and 2024, with a growth rate of 26.5%. The market showed an expanding trend with increasing momentum over the years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Generic Oncology Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Generic Oncology Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Generic Oncology Drug Market - Industry Life Cycle |
3.4 India Generic Oncology Drug Market - Porter's Five Forces |
3.5 India Generic Oncology Drug Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 India Generic Oncology Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 India Generic Oncology Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Generic Oncology Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Rising prevalence of cancer cases in India |
4.2.2 Increasing demand for cost-effective treatment options |
4.2.3 Government initiatives to promote generic drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Price erosion due to intense competition among generic drug manufacturers |
5 India Generic Oncology Drug Market Trends |
6 India Generic Oncology Drug Market, By Types |
6.1 India Generic Oncology Drug Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 India Generic Oncology Drug Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 India Generic Oncology Drug Market Revenues & Volume, By Lungs and Bronchus Cancer, 2021- 2031F |
6.1.4 India Generic Oncology Drug Market Revenues & Volume, By Colon and Rectal Cancer, 2021- 2031F |
6.1.5 India Generic Oncology Drug Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.6 India Generic Oncology Drug Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.7 India Generic Oncology Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Generic Oncology Drug Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 India Generic Oncology Drug Market Revenues & Volume, By Oral Drugs, 2021- 2031F |
6.2.3 India Generic Oncology Drug Market Revenues & Volume, By Injectables, 2021- 2031F |
6.2.4 India Generic Oncology Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Generic Oncology Drug Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Generic Oncology Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.3 India Generic Oncology Drug Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
7 India Generic Oncology Drug Market Import-Export Trade Statistics |
7.1 India Generic Oncology Drug Market Export to Major Countries |
7.2 India Generic Oncology Drug Market Imports from Major Countries |
8 India Generic Oncology Drug Market Key Performance Indicators |
8.1 Average selling price of generic oncology drugs |
8.2 Number of new product launches in the generic oncology drug market |
8.3 Adoption rate of generic oncology drugs compared to branded alternatives |
9 India Generic Oncology Drug Market - Opportunity Assessment |
9.1 India Generic Oncology Drug Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 India Generic Oncology Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 India Generic Oncology Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Generic Oncology Drug Market - Competitive Landscape |
10.1 India Generic Oncology Drug Market Revenue Share, By Companies, 2024 |
10.2 India Generic Oncology Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here